Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4282928475', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-1268', 'title': 'Abstract 1268: Early proliferative response via [18]FLT-PET/CT and serum TK1 activity are predictive biomarkers for synergistic effect of sequential cell cycle targeted therapy in sarcoma', 'display_name': 'Abstract 1268: Early proliferative response via [18]FLT-PET/CT and serum TK1 activity are predictive biomarkers for synergistic effect of sequential cell cycle targeted therapy in sarcoma', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282928475', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-1268'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-1268', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5031665612', 'display_name': 'Tuyen Duong Thanh Nguyen', 'orcid': 'https://orcid.org/0000-0003-2036-5173'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Tuyen Duong Nguyen', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025296273', 'display_name': 'Marc A. Pina', 'orcid': 'https://orcid.org/0000-0002-5676-4048'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Marc A. Pina', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100322938', 'display_name': 'Yan Wang', 'orcid': 'https://orcid.org/0000-0003-2563-255X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yan Wang', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011734599', 'display_name': 'Cansu Karakaş', 'orcid': 'https://orcid.org/0000-0003-0357-5224'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cansu Karakas', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000113218', 'display_name': 'Tuyen Bui', 'orcid': 'https://orcid.org/0000-0001-8509-3653'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Tuyen N. Bui', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5068604697', 'display_name': 'Osama Mawlawi', 'orcid': 'https://orcid.org/0000-0003-4446-5670'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Osama Mawlawi', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050445982', 'display_name': 'Alexander J. Lazar', 'orcid': 'https://orcid.org/0000-0002-6395-4499'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alexander J. Lazar', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019756853', 'display_name': 'Davis R. Ingram', 'orcid': 'https://orcid.org/0000-0001-5967-1501'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Davis R. Ingram', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109601916', 'display_name': 'Peter J. Hougton', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Peter J. Hougton', 'raw_affiliation_strings': ['2University of Texas Heath Science Center, San Antonio, TX.'], 'affiliations': [{'raw_affiliation_string': '2University of Texas Heath Science Center, San Antonio, TX.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017411324', 'display_name': 'Kelly K. Hunt', 'orcid': 'https://orcid.org/0000-0001-9156-8723'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kelly K. Hunt', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5042960706', 'display_name': 'Khandan Keyomarsi', 'orcid': 'https://orcid.org/0000-0002-5440-0849'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Khandan Keyomarsi', 'raw_affiliation_strings': ['1University of Texas MD Anderson Cancer Center, Houston, TX;'], 'affiliations': [{'raw_affiliation_string': '1University of Texas MD Anderson Cancer Center, Houston, TX;', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 60}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '1268', 'last_page': '1268'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10583', 'display_name': 'Cancer-related Molecular Pathways', 'score': 0.9883, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10583', 'display_name': 'Cancer-related Molecular Pathways', 'score': 0.9883, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12226', 'display_name': 'Neuroblastoma Research and Treatments', 'score': 0.9846, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11328', 'display_name': 'Ocular Oncology and Treatments', 'score': 0.977, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/retinoblastoma-protein', 'display_name': 'Retinoblastoma protein', 'score': 0.6185667}, {'id': 'https://openalex.org/keywords/targeted-therapy', 'display_name': 'Targeted Therapy', 'score': 0.4685099}, {'id': 'https://openalex.org/keywords/retinoblastoma', 'display_name': 'Retinoblastoma', 'score': 0.44226503}], 'concepts': [{'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6917229}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.67126435}, {'id': 'https://openalex.org/C2776062698', 'wikidata': 'https://www.wikidata.org/wiki/Q21111463', 'display_name': 'Retinoblastoma protein', 'level': 4, 'score': 0.6185667}, {'id': 'https://openalex.org/C29537977', 'wikidata': 'https://www.wikidata.org/wiki/Q188941', 'display_name': 'Cell cycle', 'level': 3, 'score': 0.58230364}, {'id': 'https://openalex.org/C2778256501', 'wikidata': 'https://www.wikidata.org/wiki/Q223911', 'display_name': 'Sarcoma', 'level': 2, 'score': 0.5161463}, {'id': 'https://openalex.org/C2780258809', 'wikidata': 'https://www.wikidata.org/wiki/Q414143', 'display_name': 'Gemcitabine', 'level': 3, 'score': 0.5034508}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.48273724}, {'id': 'https://openalex.org/C199835354', 'wikidata': 'https://www.wikidata.org/wiki/Q15311861', 'display_name': 'Cyclin D1', 'level': 4, 'score': 0.48231435}, {'id': 'https://openalex.org/C2781230642', 'wikidata': 'https://www.wikidata.org/wiki/Q492646', 'display_name': 'Targeted therapy', 'level': 3, 'score': 0.4685099}, {'id': 'https://openalex.org/C62112901', 'wikidata': 'https://www.wikidata.org/wiki/Q189159', 'display_name': 'Cell growth', 'level': 2, 'score': 0.44365576}, {'id': 'https://openalex.org/C2776577112', 'wikidata': 'https://www.wikidata.org/wiki/Q500695', 'display_name': 'Retinoblastoma', 'level': 3, 'score': 0.44226503}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.413807}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3239133}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.29153287}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.25117332}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-1268', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.86, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4211046008', 'https://openalex.org/W3092184089', 'https://openalex.org/W2187684008', 'https://openalex.org/W2107866180', 'https://openalex.org/W2078990441', 'https://openalex.org/W2062123110', 'https://openalex.org/W2053984905', 'https://openalex.org/W2025982955', 'https://openalex.org/W2023204707', 'https://openalex.org/W2009573109'], 'abstract_inverted_index': {'Abstract': [0], 'Introduction:': [1], 'Sarcomas': [2], 'are': [3, 60, 461], 'rare,': [4], 'aggressive': [5, 37, 419], 'tumors': [6], 'that': [7, 82], 'make': [8], 'up': [9], 'a': [10, 137], 'higher': [11], 'percentage': [12], 'of': [13, 24, 76, 86, 97, 108, 119, 125, 130, 147, 257, 275, 305, 312, 320, 380, 394, 467, 478], 'overall': [14], 'cancer': [15], 'mortality': [16], 'in': [17, 61, 67, 71, 105, 221, 227, 229, 232, 235, 239, 272, 278, 294, 307, 314, 331, 358, 362, 400, 473], 'children': [18], 'and': [19, 48, 73, 152, 169, 201, 210, 224, 231, 303, 335, 374, 457], 'young': [20], 'adults.': [21], 'Primary': [22], 'management': [23], 'sarcoma': [25, 77, 149, 248, 474], 'patients': [26, 41], 'includes': [27], 'surgical': [28], 'resection': [29], 'with': [30, 36, 42, 162, 171, 192, 299, 365, 388, 402], 'adjuvant': [31], 'or': [32, 194, 322, 353], 'neoadjuvant': [33], 'radiation/chemotherapy.': [34], 'Even': [35], 'multimodal': [38], 'treatment': [39, 191, 225, 242, 344, 384], 'regimens,': [40], 'high-grade': [43], 'sarcomas': [44, 109], 'experience': [45], 'suboptimal': [46], 'prognosis': [47], 'advanced': [49], 'disease': [50], 'is': [51, 115], 'almost': [52], 'universally': [53], 'fatal.': [54], 'Innovative': [55], 'biomarker': [56], 'driven': [57], 'targeted': [58, 471], 'therapies': [59], 'urgent': [62], 'need': [63], 'to': [64, 184, 196, 218, 241, 253, 260, 280, 327, 382, 397, 405, 410], 'improve': [65], 'survival': [66], 'these': [68], 'patients.': [69], 'Discoveries': [70], 'molecular': [72], 'genetic': [74], 'basis': [75], 'have': [78], 'revealed': [79], 'new': [80, 141], 'targets': [81], 'deserve': [83], 'consideration.': [84], 'Inactivation': [85], 'retinoblastoma': [87], '(Rb)': [88], 'pathway,': [89], 'which': [90], 'causes': [91], 'unabated': [92], 'cell': [93, 120, 150, 222, 236, 249, 276, 329, 333, 360, 395, 469], 'proliferation,': [94], 'through': [95, 123], 'overexpression': [96], 'cyclin': [98], 'D1': [99], 'and/or': [100], 'CDK4/6': [101, 134, 179, 281], 'has': [102], 'been': [103], 'detected': [104], 'the': [106, 126, 186, 198, 254, 347, 383, 407, 479], 'majority': [107], 'even': [110], 'when': [111], 'wild-type': [112, 366], 'Rb': [113, 131, 165, 174, 187, 266, 348], 'protein': [114], 'expressed.': [116], 'Hence,': [117], 'inhibition': [118], 'cycle': [121, 237, 277, 470], 'progression': [122], 'reactivation': [124], 'tumor': [127], 'suppressor': [128], 'function': [129], 'by': [132, 190, 351], 'inhibiting': [133, 346], 'activity': [135, 256, 460], 'poses': [136], 'potential': [138], 'avenue': [139], 'for': [140, 417, 464, 482], 'therapeutic': [142, 318], 'options.': [143], 'Methods:': [144], 'A': [145], 'panel': [146], '4': [148, 153], 'lines': [151, 250, 334], 'patient': [154], 'derived': [155], 'xenograft': [156], '(PDX)': [157], 'models': [158, 287, 390], 'were': [159, 216, 243, 251], 'used:': [160], '2': [161, 170], 'an': [163, 172, 342], 'intact': [164], 'pathway': [166, 175, 188, 349, 355], '(Rb+ve,': [167], 'p16-ve)': [168], 'altered': [173], '(Rb': [176], 'low/-ve,': [177], 'p16+ve).': [178], 'inhibitor,': [180], 'abemaciclib,': [181], 'was': [182], 'used': [183, 217, 399], 'reactivate': [185], 'followed': [189, 350], 'gemcitabine': [193], 'WEE1-kinase-inhibitor,': [195], 'target': [197], 'enriched': [199], 'S': [200, 308, 315, 352], 'G2/M': [202, 323, 354], 'phase': [203, 274, 316], 'cells': [204, 268, 306, 313], 'post-abemaciclib': [205], 'removal.': [206], '18F-FLT': [207, 295], 'PET': [208, 372, 403], 'imaging': [209, 373, 404], 'serum': [211, 301, 375, 458], 'thymidine': [212], 'kinase': [213], '1': [214], '(TK1)': [215], 'monitor': [219], 'changes': [220], 'proliferation': [223, 396], 'response': [226, 240, 279, 381, 454], 'both': [228], 'vitro': [230], 'vivo.': [233], 'Changes': [234], 'biomarkers': [238, 393, 463], 'also': [244, 369, 391], 'interrogated.': [245], 'Results:': [246], 'Rb+ve': [247, 286, 332], 'sensitive': [252], 'anti-proliferative': [255], 'abemaciclib': [258], 'leading': [259, 326], 'their': [261], 'reversible': [262], 'G1': [263], 'arrest,': [264], 'while': [265], 'null': [267], 'did': [269], 'not': [270, 289], 'arrest': [271], 'any': [273], 'inhibition.': [282], 'Following': [283], 'abemciclib': [284], 'removal,': [285], '(but': [288], 'Rb-ve)': [290], 'showed': [291], 'significant': [292], 'increase': [293], 'biotracer': [296], 'uptake': [297], 'concomitant': [298], 'elevated': [300], 'TK1': [302, 376, 459], 'enrichment': [304, 311], 'phase.': [309], 'The': [310, 386], 'maximized': [317], 'efficacy': [319], 'S-phase': [321], 'targeting': [324], 'agents': [325], 'synergistic': [328, 359, 465], 'killing': [330, 361], 'PDX': [336, 389], 'models.': [337], 'Conclusion:': [338], 'Our': [339], 'study': [340, 387], 'presents': [341], 'innovative': [343], 'strategy': [345], 'sequentially': [356], 'resulting': [357], 'those': [363], 'cells/tumors': [364], 'Rb.': [367], 'We': [368], 'incorporate': [370], 'real-time': [371], 'as': [377], 'non-invasive': [378], 'indicators': [379], 'strategy.': [385], 'identified': [392], 'be': [398], 'conjunction': [401], 'provide': [406], 'pre-clinical': [408], 'rationale': [409], 'translate': [411], 'our': [412], 'findings': [413], 'into': [414], 'clinical': [415], 'trials': [416], 'this': [418], 'disease.': [420], 'Citation': [421], 'Format:': [422], 'Tuyen': [423, 433], 'Duong': [424], 'Nguyen,': [425], 'Marc': [426], 'A.': [427], 'Pina,': [428], 'Yan': [429], 'Wang,': [430], 'Cansu': [431], 'Karakas,': [432], 'N.': [434], 'Bui,': [435], 'Osama': [436], 'Mawlawi,': [437], 'Alexander': [438], 'J.': [439, 445], 'Lazar,': [440], 'Davis': [441], 'R.': [442], 'Ingram,': [443], 'Peter': [444], 'Hougton,': [446], 'Kelly': [447], 'K.': [448], 'Hunt,': [449], 'Khandan': [450], 'Keyomarsi.': [451], 'Early': [452], 'proliferative': [453], 'via': [455], '[18]FLT-PET/CT': [456], 'predictive': [462], 'effect': [466], 'sequential': [468], 'therapy': [472], '[abstract].': [475], 'In:': [476], 'Proceedings': [477], 'American': [480], 'Association': [481], 'Cancer': [483, 494], 'Research': [484], 'Annual': [485], 'Meeting': [486], '2022;': [487], '2022': [488], 'Apr': [489], '8-13.': [490], 'Philadelphia': [491], '(PA):': [492], 'AACR;': [493], 'Res': [495], '2022;82(12_Suppl):Abstract': [496], 'nr': [497], '1268.': [498]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282928475', 'counts_by_year': [], 'updated_date': '2024-12-09T14:01:50.686504', 'created_date': '2022-06-16'}